Covestor’s Eton Pharmaceutcials ETON Stock Holding History

Covestor’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1K	Sell	16 -12	-43%	-$352	﹤0.01%	2137
2026 Q1	$1K	Buy	+28	New	+$490	﹤0.01%	2028

Other funds holding ETON

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

Covestor's ETON Position: Q2 2026 in Review

Covestor reduced its Eton Pharmaceutcials (ETON) stake by 43% in Q2 2026, selling an estimated $352 and leaving 16 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2137.

Covestor first reported a position in ETON in Q1 2026 and has held it in 2 quarters since. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

Covestor held 16 shares of Eton Pharmaceutcials worth $1K as of Q2 2026.
Covestor sold 12 Eton Pharmaceutcials shares in Q2 2026, an estimated $352.
Eton Pharmaceutcials made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2137 holding.
Covestor first reported a position in Eton Pharmaceutcials in Q1 2026 and has held it in 2 quarters since.
164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.